Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.93−0.08 (-3.98%)
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
Ernexa Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ernexa Therapeutics's enterprise value was -$2.77M on Nov 11, 2026, against $261.86M a year earlier. Over the last 5 years it ranged from -$5.35M to $1.63T, with a median of $3.54B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.77M | -101.2% |
| 2025 | Dec 31, 2025 | $232.42M | -60.8% |
| 2024 | Dec 31, 2024 | $592.27M | -83.8% |
| 2023 | Dec 29, 2023 | $3.65B | +3.1% |
| 2022 | Dec 30, 2022 | $3.54B | -99.8% |
| 2021 | Dec 31, 2021 | $1.63T | +173.5% |
| 2020 | Dec 31, 2020 | $595.12B | +3.8% |
| 2019 | Dec 31, 2019 | $573.21B | +13.7% |
| 2018 | Dec 31, 2018 | $504.04B | +52728.4% |
| 2017 | Dec 29, 2017 | $954.10M | -99.9% |
| 2016 | Dec 30, 2016 | $1.41T | +6.3% |
| 2015 | Dec 31, 2015 | $1.33T | -63.6% |
| 2014 | Dec 31, 2014 | $3.65T | +89755.1% |
| 2013 | Dec 31, 2013 | $4.07B | +203.5% |
| 2012 | Dec 31, 2012 | $1.34B | -2.0% |
| 2011 | Dec 30, 2011 | $1.37B | – |
See a number that looks wrong?